Related references
Note: Only part of the references are listed.Phase I and pharmacokinetic study of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin
Clemens Unger et al.
CLINICAL CANCER RESEARCH (2007)
2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline
Thomas J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives.: Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound
F Kratz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
